Phone app to support families at home after a child's heart surgery
Tests WeChat app support for families after congenital heart disease surgery.
Key facts
- Who runs it
- ruijie YangLan
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Design and Application of a Home Care WeChat Mini-Program for Children After Congenital Heart Disease Surgery
- Status
- Not yet recruiting
- People taking part
- 210 people, planned
- Started
- 30 Mar 2026
- Expected to end
- 30 Mar 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Home Care WeChat Mini-Program
- Routine Care with Telephone Follow-up
- Record updated
- 4 February 2026
Who can take part
The trial is looking for children aged 12 or younger with congenital heart disease (a heart problem present from birth) who will have or have had corrective surgery, together with a main caregiver. It tests a WeChat home care mini-program against routine telephone follow-up.
- Age
- 0 Years to 12 Years (child). Caregivers who are siblings must be older than 12 years.
- Sex
- All
- Disease stage
- Congenital heart disease, with corrective surgery planned or already done. The child must be medically stable, not in an acute phase.
- Earlier treatment
- The child is scheduled for or has had corrective heart surgery.
- Main reasons for not taking part
- The child has severe developmental defects.
- The child has other major diseases that strongly affect quality of life.
- The caregiver has sight, hearing or thinking problems that make communication hard.
- The caregiver has a diagnosed psychiatric disorder.
- The caregiver is unconscious or cannot give consent.
Show the full registry criteria (10)Hide the full registry criteria
Who can take part
- - The child is ≤12 years old
- The child has been diagnosed with congenital heart disease (CHD) and is scheduled for or has undergone corrective surgery
- The child is in a stable medical condition (non-acute phase)
- At least one primary caregiver (parent or sibling >12 years old) of the child agrees to participate
- The caregiver provides written informed consent to participate in the study
Who cannot take part
- The child has other major diseases that significantly affect quality of life
- The caregiver has a diagnosed psychiatric disorder
- - The child has severe developmental defects
- The caregiver has visual, hearing, or cognitive impairments that hinder communication
- The caregiver is unconscious or otherwise unable to provide consent
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Congenital heart disease
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This is a single-blind, randomized controlled trial aimed at evaluating the effectiveness of a family-centered, WeChat-based home care mini-program for children after congenital heart disease (CHD) surgery. Given the chronic nature of post-operative CHD management and the significant stress placed on families, this study shifts from a deficit-based to a strengths-based perspective, guided by the Double ABC-X model. Children (≤12 years old) who have undergone CHD surgery and their primary caregivers will be recruited. Participants will be randomly assigned to either the intervention group, which uses the mini-program for health education, peer support, and physiological monitoring, or the control group, which receives routine telephone follow-up. The primary outcomes are family health (measured by the Family Health Scale), family stress, and the quality of life for both the child and caregivers. Secondary outcomes include physiological parameters such as the 6-minute walk test distance. The study aims to provide evidence for a scalable digital health intervention to support long-term family adaptation and child recovery.
The 2 groups in the trial
- Intervention GroupTreatment being tested
Participants receiving the WeChat mini-program intervention.
Treatment: Routine Care with Telephone Follow-up
- Control GroupExisting treatment, for comparison
Participants receiving routine care with telephone follow-up.
Treatment: Home Care WeChat Mini-Program
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Design and Application of a Home Care Mini-Program for Children With Congenital Heart Disease After Discharge: A Randomized Controlled Trial
- Plain-language title
- Phone app to support families at home after a child's heart surgeryGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Criteria questions
- Built from NCT07385209, who can take part
- Record updated
- 4 February 2026